Use Of Mesenchymal Stem Cells For The Improvement Of Affective And Cognitive Function

Disclosed is the use of mesenchymal stem cells (MSCs) and in particular MSCs pretreated with pituitary adenylate cyclase-activating polypeptide (PACAP) or analogs and fragments of PACAP, for treatment of neurodegenerative and psychiatric diseases, and for the improvement of affective and cognitive function in a normal individual or in an individual suffering from a neurodegenerative or neuropsychiatric disease.

URL: http://www.google.com/patents/US20140105871

Published on 12-17-2014